Clinical Trials Logo

Filter by:
NCT ID: NCT02051608 Completed - Alzheimer's Disease Clinical Trials

A Study of Gantenerumab in Participants With Mild Alzheimer Disease

Start date: March 27, 2014
Phase: Phase 3
Study type: Interventional

Part 1 is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of gantenerumab in participants with mild Alzheimer disease. Participants will be randomized to receive either gantenerumab subcutaneously every 4 weeks or placebo subcutaneously every 4 weeks. Approved Alzheimer medication is allowed if on stable dose for 3 months prior to screening. Part 2 is an open-label extension (OLE). A positron emission tomography (PET) imaging substudy will be conducted within the main study. Eligible participants who provide separate informed consent will undergo PET imaging scans using the radioligand florbetapir as a pharmacodynamic measure of changes in brain amyloid load over time.

NCT ID: NCT02051478 Completed - Neck Pain Clinical Trials

Thoracic Manipulation and Mobilization for Neck Pain

Start date: September 2012
Phase: N/A
Study type: Interventional

The purpose of this randomized clinical trial was to examine the widespread effects of thoracic spine thrust manipulation and thoracic non-thrust mobilization on pressure pain sensitivity and neck pain intensity in patients with chronic mechanical neck pain.

NCT ID: NCT02051270 Completed - Clinical trials for Mild Cognitive Impairment

Cognitive Impairment and Balance in Elderly

Start date: January 2014
Phase: N/A
Study type: Observational

One important issue in older adults with cognitive problems is the higher risk of fall due to decreased motor function and balance. The objective of this study is to evaluate the repercussions of mild cognitive impairment in balance in elderly.

NCT ID: NCT02051023 Completed - Dry Eye Clinical Trials

Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)

FML
Start date: February 2014
Phase: Phase 3
Study type: Interventional

Hypothesis: Fluorometholone (FML) 0.1% eyedrops topically applied 4 times a day for 22 days is more efficient than artificial tears (Liquifilm) in dry eye disease (DED) and ameliorates the worsening of the disease after exposure to an adverse controlled environment.

NCT ID: NCT02050503 Completed - Clinical trials for Head and Neck Cancer

Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis

CP073
Start date: December 2012
Phase: N/A
Study type: Observational

An open-label, non-randomized study to assess the titration, safety and efficacy of intranasal fentanyl pectin nasal spray for the treatment of secondary breakthrough pain secondary to radiation-induced mucositis in patients with confirmed tolerance of opioid therapy for chronic pain. Study objectives include assessment of breakthrough pain episodes related with food intake in patients with mucositis secondary to radiotherapy or radio-chemotherapy for head and neck tumors

NCT ID: NCT02050438 Completed - Clinical trials for Total Knee Replacement

How Total Knee Prosthesis Dessigns Influence in Quality of Live

Start date: January 2014
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether different kind of prostesis designs influences in the quality of life of patients

NCT ID: NCT02049905 Completed - Clinical trials for Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Start date: January 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of aldoxorubicin in subjects with metastatic, locally advanced, or unresectable soft tissue sarcomas.

NCT ID: NCT02049840 Completed - Clinical trials for Stress Urinary Incontinence

The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence

EASY
Start date: December 16, 2013
Phase: N/A
Study type: Interventional

This is a prospective, post-market, single arm, multicenter study comparing Baseline data to the 12 month and 36 month data in 136 female patients with Stress Urinary Incontinence

NCT ID: NCT02049515 Completed - Clinical trials for Chronic Lymphocytic Leukemia

A Phase 3 Extension Study of Duvelisib and Ofatumumab in Participants With CLL/SLL Previously Enrolled in Study IPI-145-07

Start date: December 2013
Phase: Phase 3
Study type: Interventional

A Phase 3 (extension) clinical trial to examine the efficacy of IPI-145 (duvelisib) monotherapy or ofatumumab monotherapy in participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who experienced disease progression after treatment with IPI-145 or ofatumumab in study IPI-145-07 (NCT02004522).

NCT ID: NCT02049138 Completed - Clinical trials for Rheumatoid Arthritis

An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis

BALANCE-EXTEND
Start date: January 24, 2014
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to evaluate the long-term safety, tolerability, and efficacy of upadacitinib in adults with rheumatoid arthritis (RA) who have completed a preceding randomized controlled trial with upadacitinib.